Skip to main content
Log in

In vitro and In vivo Determination of Biological Activities of Bitter Gourd (Momordica charantia L.) Peel, Flesh and Seeds

  • Research
  • Published:
Plant Foods for Human Nutrition Aims and scope Submit manuscript

Abstract

Momordica charantia L. has been remained a well-known medicinal vegetable used traditionally. However, which part is most effective against which disorder, has been remained undiscovered yet. The objective of this study was to examine the antimicrobial, antihyperlipidemic and antihyperglycemic activities of peel, flesh, and seeds of bitter gourd, through in vitro and in vivo assays. Ethanolic extracts from powders of three fractions of bitter gourd were assessed for antimicrobial potential against bacterial and fungal strains, whereas, powders of these fractions were used to determine antihyperlipidemic and antihyperglycemic activity, in alloxan induced diabetic rats. Our results showed that BSE exhibited better antimicrobial activity against Bacillus cereus, whereas BFE exhibited better against Escherichia coli. Blood glucose was significantly lowered by all three powders in a dose dependent manner, when fed to diabetic rats, with the highest decrease by BSP, which reduced the glucose level from 296.20 ± 2.00 mg/dl to 123.10 ± 0.80 mg/dl, at 15 mg dose, after 28 days trial. Elevated levels of TC (101.18 ± 0.65 mg/dl), TG (83.69 ± 0.61 mg/dl) and LDL–C (25.90 ± 0.09 mg/dl) in positive control rats were lowered down in well manners by BSP at 15 mg dose, to 86.30 ± 0.53, 67.70 ± 0.53 and 19.32 ± 0.06 mg/dl, respectively. As compared to BFP and BPP, BSP showed significant involvement in antibacterial, antihyperglycemic, and antihyperlipidemic actions. Along with the edible flesh, peels and seeds, which are usually discarded as waste, could also be utilized for development of pharma foods capable of promoting health.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data Availability

Data relevant to this study can be provided upon request from corresponding author.

References

  1. Mahwish SF, Sultan MT, Riaz A et al (2021) Bitter melon (Momordica charantia L.) fruit bioactives charantin and vicine potential for diabetes prophylaxis and treatment. Plants 10:730. https://doi.org/10.3390/plants10040730

  2. Singh P, Tripathi MK, Yasir M et al (2020) Potential inhibitors for SARS-CoV-2 and functional food components as nutritional supplement for COVID-19: a review. Plant Foods Hum Nutr 75:458–466. https://link.springer.com/article/https://doi.org/10.1007/s11130-020-00861-9

    Article  CAS  Google Scholar 

  3. Hussain A, Kausar T, Sehar S et al (2023) A review on biochemical constituents of pumpkin and their role as pharma foods; a key strategy to improve health in post COVID 19 period. Food Prod Proces Nutr 5:22. https://fppn.biomedcentral.com/articles/https://doi.org/10.1186/s43014-023-00138-z

    Article  CAS  Google Scholar 

  4. Gayathry KS, John JA et al (2022) A comprehensive review on bitter gourd (Momordica charantia L.) as a gold mine of functional bioactive components for therapeutic foods. Food Prod Proces Nutr 4:10. https://doi.org/10.1186/s43014-022-00089-x

    Article  Google Scholar 

  5. Valyaie A, Azizi M, Kashi A et al (2021) Evaluation of growth, yield, and biochemical attributes of bitter gourd (Momordica charantia L.) cultivars under Karaj conditions in Iran. Plants 10:1370. https://doi.org/10.3390/plants10071370

  6. Semiz A, Sen A (2007) Antioxidant and chemoprotective properties of Momordica charantia L. (bitter melon) fruit extract. Afr J Biotech 6:273–277. https://www.ajol.info/index.php/ajb/article/view/56180

    Google Scholar 

  7. Tan SP, Stathopoulos C, Parks S et al (2014) An Optimised Aqueous Extract of Phenolic compounds from bitter melon with high antioxidant capacity. Antioxidants 3:814–829. https://doi.org/10.3390/antiox3040814

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kulkarni P, Lohidasan S, Mahadik K et al (2021) Isolation, characterisation and investigation of in vitro antidiabetic and antioxidant activity of phytoconstituents from fruit of Momordica charantia Linn. Nat Prod Res 35:1035–1037. https://doi.org/10.1080/14786419.2019.1613400

  9. Lee SH, Jeong YS, Song J et al (2017) Phenolic acid, carotenoid composition, and antioxidant activity of bitter melon (Momordica charantia L.) at different maturation stages. Int J Food Prop 20:S3078–S3087. https://doi.org/10.1080/10942912.2016.1237961

    Article  CAS  Google Scholar 

  10. Lucas EA, Dumancas GG, Smith BJ et al (2010) Health benefits of bitter melon (Momordica charantia). Bioactive foods in promoting health. Elsevier, pp 525–549. https://doi.org/10.1016/B978-0-12-374628-3.00035-9

  11. Perera WH, Shivanagoudra SR, Pérez JL et al (2021) Anti-inflammatory, antidiabetic properties and in silico modeling of cucurbitane-type triterpene glycosides from fruits of an Indian cultivar of Momordica charantia L. Molecules 26:1038. https://doi.org/10.3390/molecules26041038

  12. Xu B, Li Z, Zeng T et al (2022) Bioactives of Momordica charantia as potential anti-diabetic/hypoglycemic agents. Molecules 27:2175. https://doi.org/10.3390/molecules27072175

  13. Richter E, Geetha T, Burnett D et al (2023) The effects of Momordica charantia on type 2 diabetes mellitus and Alzheimer’s disease. Int J Mol Sci 24:4643. https://doi.org/10.3390/ijms24054643

  14. Asif M, Naqvi SAR, Sherazi TA et al (2017) Antioxidant, antibacterial and antiproliferative activities of pumpkin (cucurbit) peel and puree extracts - an in vitro study. Pak J Pharma Sci 30:1327–1334. http://www.pjps.pk/uploads/pdfs/30/4/Paper-20.pdf

    CAS  Google Scholar 

  15. Hussain A, Kausar T, Din A et al (2021) Antioxidant and antimicrobial properties of pumpkin (Cucurbita maxima) peel, flesh and seeds powders. Biol Agric Healthc 11:42–51. https://doi.org/10.7176/JBAH/11-6-05

  16. Hannan JMA, Rokeya B, Faruque O et al (2003) Effect of soluble dietary fibre fraction of Trigonella foenum graecum on glycemic, insulinemic, lipidemic and platelet aggregation status of type 2 diabetic model rats. J Ethnopharmacol 88:73–77. https://doi.org/10.1016/S0378-8741(03)00190-9

    Article  CAS  PubMed  Google Scholar 

  17. Zhu Y, Dong Y, Qian X et al (2012) Effect of superfine grinding on antidiabetic activity of bitter melon powder. Int J Mol Sci 13:14203–14218. https://doi.org/10.3390/ijms131114203

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Caili F, Huan S, Quanhong L (2006) A review on pharmacological activities and utilization technologies of pumpkin. Plant Foods Hum Nutr 61: 73–80. https://link.springer.com/article/10.1007/s11130-006-0016-6

  19. Ozusaglam MA, Karakoca K (2016) Antimicrobial and antioxidant activities of Momordica charantia from Turkey. Afric J Biotech 12:1548–1558. https://www.ajol.info/index.php/ajb/article/view/128722

    Google Scholar 

  20. Hussain A, Kausar T, Jamil MA et al (2022) In vitro role of pumpkin parts as pharma-foods: antihyperglycemic and antihyperlipidemic activities of pumpkin peel, flesh, and seed powders, in alloxan-induced diabetic rats. Int J Food Sci 2022:4804408. https://doi.org/10.1155/2022/4804408

  21. Degré R, Sylvestre M (1983) Effect of butylated hydroxyanisole on the cytoplasmic membrane of Staphylococcus aureus Wood 46. J Food Protec 46:206–209. https://doi.org/10.4315/0362-028X-46.3.206

    Article  Google Scholar 

  22. Adams GG, Imran S, Wang S et al (2011) The hypoglycaemic effect of pumpkins as anti-diabetic and functional medicines. Food Res Int 44:862–867. https://doi.org/10.1016/j.foodres.2011.03.016

    Article  CAS  Google Scholar 

  23. Huang CY, Chen SD (2022) Application of high pressure processing on ultrasonically treated extract from wild bitter gourd. Processes 10:1926. https://doi.org/10.3390/pr10101926

    Article  CAS  Google Scholar 

  24. Al-Bukhaiti WQ, Al-Dalali S, Li H et al (2023) Identification and in vitro characterization of novel antidiabetic peptides released enzymatically from peanut protein. Plant Foods Hum Nutr 78:1–7. https://link.springer.com/article/10.1007/s11130-023-01118-x

  25. Białek A, Jelińska M, Białek M et al (2020) The effect of diet supplementation with pomegranate and bitter melon on Lipidomic profile of serum and cancerous tissues of rats with mammary tumours. Antioxid (Basel) 9:243. https://doi.org/10.3390/antiox9030243

    Article  CAS  Google Scholar 

  26. Etgeton SAP, Ávila S, Silva ACR et al (2023) Nutritional composition, simulated digestion and biological activities of Campomanesia xanthocarpa fruit. Plant Foods Hum Nutr 78: 1–7. https://link.springer.com/article/10.1007/s11130-023-01126-x

  27. Ference BA, Ginsberg HN, Graham I et al (2017) Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 38:2459–2472. https://doi.org/10.1093/eurheartj/ehx144

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Gazwi HS, Hassan MS, Ismail HA, El-Naem GFA, Tony SK (2023) The hypoglycemic and hypolipidemic effects of polyphenol-rich strawberry juice on diabetic rats. Plant Foods Hum Nutr 78: 512–519. https://link.springer.com/article/10.1007/s11130-023-01079-1

Download references

Funding

No funds in any form, from any source were availed for this research work.

Author information

Authors and Affiliations

Authors

Contributions

A. H. and S. A. K. Conceptualization; K. K. and A. S. Data curation; M. R. A. Formal analysis; H. F Funding acquisition, Investigation; S. A. Methodology, Project administration; S. A. and S. A. K. Resources; S. K. and A. A. Software; A. H. Supervision; M. Q. A Validation, Visualization; A. H. Roles/Writing – original draft; A. H., S. Y. and S. A. K, Writing – review and editing.

Corresponding author

Correspondence to Ashiq Hussain.

Ethics declarations

Ethical Approval

This study involved experiments on rats. Therefore, appropriate protocols for protecting the ethical rights of all animals were utilized during the execution of the research. This study was approved by Animal Ethical Committee, College of Biochemistry & Pharmacy, University of Sargodha (SU/AESC/283/Nov/23/2021), for 3 months trials.

Consent for publication

Not applicable.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hussain, A., Korma, S.A., Kabir, K. et al. In vitro and In vivo Determination of Biological Activities of Bitter Gourd (Momordica charantia L.) Peel, Flesh and Seeds. Plant Foods Hum Nutr (2024). https://doi.org/10.1007/s11130-024-01153-2

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11130-024-01153-2

Keywords

Navigation